A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis
Clinical trial NCT06923228 · COMPLETED
Trial details
- NCT number
- NCT06923228
- Sponsor
- CAGE Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-21
- Primary completion
- 2025-07-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.